cellamare-m 1

1. Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial
2. Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis
1